Xintian Pharma(SZ:002873) Zheng Quan Shi Bao Wang·2024-11-04 03:50Group 1 - The 2024 Wanmeng Conference, themed "The Birth of Future Pharmacies," was held in Zhejiang Changxing, gathering industry leaders to discuss high-quality development in the pharmaceutical retail sector [1] - New Tian Pharmaceutical's two core products, He Yan® Kun Tai Capsules and Kun Li Shu® Ku Shen Gel, won the "Changxing Gold Award" for their outstanding performance in the gynecology category [1][2] - The "Changxing Gold Award" is recognized for its high credibility and industry influence, awarded to brands with exceptional quality and reputation [1] Group 2 - New Tian Pharmaceutical has a strong foundation in traditional Chinese medicine and has developed several patented products, gaining significant recognition in the industry [2] - The He Yan® Kun Tai Capsule is a patented traditional Chinese medicine approved for improving symptoms related to ovarian function decline, ranking first in both hospital and retail sectors in 2022 [2][3] - The Kun Li Shu® Ku Shen Gel is the first vaginal carbomer gel in China, effective in treating bacterial vaginosis and yeast infections, with high clinical value and consumer recognition [3] Group 3 - Shanghai Huilun Pharmaceutical, a subsidiary of New Tian Pharmaceutical, also received awards, with its product Xiong Xiong® Avanafil Tablets winning in the male health category [4] - Both New Tian Pharmaceutical and Huilun Pharmaceutical emphasize innovation and high clinical value in their drug development, with both companies recognized in the "2024 China Pharmaceutical R&D Strength Top 100" and "2024 China Traditional Chinese Medicine R&D Strength Top 50" [4]